跳至主要内容
临床试验/JPRN-UMIN000027618
JPRN-UMIN000027618暂停未知

The effect of an anti-VEGF drug on proliferative diabetic retinopathy complicated with diabetic macular edema - The effect of an anti-VEGF drug on proliferative diabetic retinopathy

Tokyo Women's Medical University0 个研究点目标入组 30 人开始时间: 2017年6月3日最近更新:
适应症

试验速览

阶段
未知
状态
暂停
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • In case of receiving intravitreal administration of anti-VEGF drug within 3 months before enrollment. When panretinal or partial retinal photocoagulation was performed for the purpose of treatment against diabetic retinopathy within 3 months before starting participation. During systemic administration of anti-VEGF drug. Pregnant women or potential patients. Patients judged inappropriate as subjects by research managers.

研究者

发起方
Tokyo Women's Medical University

相似试验